BILL REQ. #: S-0771.1
State of Washington | 61st Legislature | 2009 Regular Session |
Read first time 01/19/09. Referred to Committee on Health & Long-Term Care.
AN ACT Relating to providing safe collection and disposal of unwanted drugs from residential sources through a producer provided and funded product stewardship program; reenacting and amending RCW 69.41.030; adding a new chapter to Title 70 RCW; creating a new section; and prescribing penalties.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF WASHINGTON:
NEW SECTION. Sec. 1 The citizens of Washington state have long
benefited from prescription and nonprescription medicines. These
medicines allow us to live longer, healthier, and more productive
lives. After they have served their intended use, expired or left-over
drugs need to be handled safely and disposed of properly to prevent
harm to people and our environment. The legislature finds that a
convenient, safe, secure, and environmentally sound product stewardship
program for the collection, transportation, and disposal of unwanted
drugs from residential sources may help to avoid accidental poisonings,
decrease illegitimate access to drugs that can lead to abuse, and
protect our surface and groundwater. The legislature further finds
that producers of those drugs are the best entity to provide and
finance the product stewardship program.
NEW SECTION. Sec. 2 The definitions in this section apply
throughout this chapter unless the context clearly requires otherwise.
(1) "Board" means the Washington state board of pharmacy.
(2) "Covered product" means all legend and nonlegend drugs,
including both brand name and generic drugs.
(3) "Department" means the department of ecology.
(4) "Drug wholesalers" means businesses that sell or distribute for
resale drugs to any entity other than the consumer.
(5) "Drugs" means:
(a) Articles recognized in the official United States
pharmacopoeia, the official national formulary, the official
homeopathic pharmacopoeia of the United States, or any supplement of
the formulary or those pharmacopoeias;
(b) Substances intended for use in the diagnosis, cure, mitigation,
treatment, or prevention of disease in humans or other animals;
(c) Substances, other than food, intended to affect the structure
or any function of the body of humans or other animals; or
(d) Substances intended for use as a component of any substances
specified in (a), (b), or (c) of this subsection, but not including
medical devices or their component parts or accessories.
(6) "Entity" means a person other than a natural person.
(7) "Generic drug" means a drug that is chemically identical or
bioequivalent to a brand name drug in dosage form, safety, strength,
route of administration, quality, performance characteristics, and
intended use. However, inactive ingredients may vary.
(8) "Legend" or "prescription" drugs means any drugs that are
required by any applicable federal or state law or regulation to be
dispensed on prescription only or are restricted to use by
practitioners only.
(9) "Nonlegend" or "nonprescription" drugs means any drugs that may
be lawfully sold without a prescription.
(10) "Person" means a firm, sole proprietorship, corporation,
limited liability company, general partnership, limited partnership,
limited liability partnership, association, cooperative, or other
entity of any kind or nature.
(11) "Plan" means a product stewardship plan required under this
chapter that describes the manner in which a product stewardship
program will be provided.
(12) "Producer" means the person who:
(a) Has legal ownership of the brand, brand name, or cobrand of the
covered product or manufactures a generic covered product sold in or
into Washington state;
(b) Imports a covered product branded or manufactured by a producer
that meets the definition under (a) of this subsection and where that
producer has no physical presence in the United States; or
(c) Sells at wholesale or retail a covered product, does not have
legal ownership of the brand, and elects to fulfill the
responsibilities of the producer for that product.
(13) "Product stewardship program" means a program for the
collection, transportation, and either recycling or disposal, or both,
of unwanted products that is financed as well as managed or provided by
the producers of those products.
(14) "Residential sources" includes single and multiple family
residences, and locations where household drugs are unused, unwanted,
disposed, or abandoned, such as hospice services, nursing homes,
boarding homes, schools, foster care, day care, and other locations
where either people or their pet animals, or both, reside on a
temporary or permanent basis. This does not include airport security,
drug seizures by law enforcement, pharmacy waste, business waste, or
any other source identified by the department as a nonresidential or
business source.
(15) "Stewardship organization" means a person designated by a
group of producers to act as an agent on behalf of each producer to
operate a product stewardship program.
(16) "Unwanted product" means any covered product no longer wanted
by its owner or that has been abandoned, discarded, or is intended to
be discarded by its owner.
NEW SECTION. Sec. 3 (1) Beginning January 1, 2012, every
producer of covered products sold in or into Washington state must
participate in a product stewardship program for unwanted products from
residential sources.
(2) Every producer must:
(a) Operate, either individually or jointly with other producers,
a product stewardship program approved by the department; or
(b) Enter into an agreement with a stewardship organization to
operate, on the producer's behalf, a product stewardship program
approved by the department.
(3) A producer, group of producers, or stewardship organization
must pay all administrative and operational costs associated with their
product stewardship program, including the cost of the collection,
transportation, and disposal of the unwanted products that are
collected from residential sources and the recycling or disposal, or
both, of its related packaging that is collected with the unwanted
product.
(4) A product stewardship program must be provided without charging
any fee at the time of sale of the covered product or at the time the
unwanted products from residential sources are delivered or collected
for disposal.
(5) Unless otherwise approved by the department, each product
stewardship program must accept all unwanted products regardless of who
produces the unwanted product.
(6) A producer, group of producers, or stewardship organization
operating or intending to operate a product stewardship program must
submit a product stewardship plan to the department prior to engaging
in the collection of unwanted covered products.
NEW SECTION. Sec. 4 A product stewardship plan must contain the
following:
(1) Contact information, including:
(a) The individual and the entity submitting the plan; and
(b) A list of all producers participating in the product
stewardship program and their contact information;
(2) A collection system provision that describes:
(a) How unwanted products from residential sources will be
collected in all counties in the state and, at a minimum, in all cities
with populations greater than ten thousand, including if applicable,
the location of each collection site and locations where mailers are
available; and
(b) How the collection system will be convenient and adequate to
serve the needs of residents in both urban and rural areas;
(3) A transportation and disposal system provision that includes
the name, location, permit status, and record of any penalties,
violations, or regulatory orders received in the previous five years by
each transporter and each hazardous waste disposal facility proposed to
be used by the product stewardship program;
(4) Secure tracking and handling provision that includes how the
unwanted products will be safely and securely tracked and handled from
collection through final disposal, and the policies and procedures to
be followed to ensure security;
(5) How the proposed product stewardship program will maximize the
recycling of packaging that is collected with and separated from the
unwanted product prior to disposal of the unwanted product, and how
patient information on that packaging will be kept secure prior to and
during recycling; and
(6) A description of the public education effort and outreach
activities required under section 8 of this act and a methodology for
evaluating the effectiveness of its outreach and program.
NEW SECTION. Sec. 5 (1) Product stewardship plans must be
submitted to the department for approval. The initial plans must be
submitted by January 1, 2011. The department may consult with other
state agencies, including the board, on any element of the plan.
(2) Within ninety days after receipt of a plan, the department
shall determine whether the plan complies with this chapter. If it
approves a plan, the department shall notify the applicant of its
approval. If it rejects a plan, the department shall notify the
applicant of its decision and its reasons for rejecting the plan. An
applicant whose plan has been rejected by the department may submit a
revised plan to the department within sixty days after receiving notice
of the rejection.
(3) At least every four years, a producer, group of producers, or
stewardship organization operating a product stewardship program must
update its product stewardship plan and submit the updated plan to the
department for review.
(4) After January 1, 2011, each new producer and each producer new
to Washington state shall obtain a letter of approval from the
department for a new plan or join an approved plan upon initiating
sales in or into this state.
NEW SECTION. Sec. 6 (1) Any proposed change to a product
stewardship plan must have prior approval of the department except for
the following:
(a) Additions or changes to collection locations for unwanted
products; or
(b) Additions of producers to a product stewardship program.
(2) The product stewardship program must inform the department of
changes in subsection (1)(a) and (b) of this section fifteen days prior
to the changes occurring.
NEW SECTION. Sec. 7 (1) On or before June 30, 2013, and in each
subsequent year, every producer, group of producers, or stewardship
organization operating a product stewardship program must prepare and
submit to the department an annual report describing the program's
activities during the previous reporting period. The report must
include the following:
(a) A list of producers participating in the product stewardship
program;
(b) The amount, by weight, of unwanted products collected from
residential sources, including the amount by weight of unwanted
products collected at each drop-off site, if applicable, and the total
amount by weight collected by a mail-back system, if applicable;
(c) A description of the collection system provided in each county
and in all cities with populations greater than ten thousand, including
the location of each collection site and locations where mailers are
provided, if applicable;
(d) The disposal facility or facilities used and facility location
or locations, and the weight of unwanted products collected from
residential sources disposed at each facility;
(e) If packaging is separated from the unwanted product prior to
the disposal of the unwanted product, the amount and percentage of
packaging recycled and the name and location of the material recovery
facility to which it is delivered;
(f) Any penalties, violations, or regulatory orders received during
the reporting period by each transporter and each disposal facility
that was used;
(g) Whether policies and procedures for collecting, transporting,
and disposing of unwanted products, as established in the plan, were
followed during the reporting period, and a description of any
noncompliance;
(h) Whether any safety or security problems occurred during
collection, transportation, or disposal of unwanted products during the
reporting period, and, if so, what changes have or will be made to
policies, procedures, or tracking mechanisms to alleviate the problem
and to improve safety and security in the future;
(i) A description of the public education and outreach activities
implemented during the reporting period, including the methodology used
and the results of evaluating the outreach and program activities;
(j) How the product stewardship program complied with any other
elements in the plan approved by the department; and
(k) Any other information that the department may reasonably
require.
(2) For the purposes of this section, "reporting period" means the
period commencing January 1st and ending December 31st of the same
calendar year.
NEW SECTION. Sec. 8 (1) A product stewardship program must
promote the use of the program and the proper disposal of drugs so that
collection options are widely understood by customers, pharmacists,
retailers of covered products, and health care practitioners including
doctors and other prescribers.
(2) A product stewardship program must establish a toll-free
telephone number and web site where collection options will be
publicized and prepare educational and outreach materials describing
where and how to return unwanted drugs to the product stewardship
program. These materials must be provided to pharmacies, health care
facilities, and other interested parties for dissemination to
residential sources.
(3) A product stewardship program must annually evaluate the
effectiveness of its outreach and program activities. This evaluation
must include the percentage of residents that are aware of the program
and to what extent residents find the program convenient.
NEW SECTION. Sec. 9 (1) Each product stewardship program must
dispose of all unwanted products from residential sources at a
hazardous waste facility. However, unwanted products from residential
sources otherwise retain all other generator exemptions for household
hazardous waste. The hazardous waste facility must be:
(a) Permitted with interim or final status under the Washington
dangerous waste rules;
(b) Authorized to manage hazardous waste by another state with a
hazardous waste program approved by the United States environmental
protection agency; or
(c) Authorized under interim status or permitted by the United
States environmental protection agency.
(2) Product stewardship programs may petition the department for
approval to use final disposal technologies that provide superior
environmental and human health protection than provided by current
hazardous waste disposal technologies for drugs if and when those
technologies are proven and available. The proposed technology must
provide equivalent protection in each, and superior protection in one
or more, of the following areas:
(a) Monitoring of any emissions or waste;
(b) Worker health and safety;
(c) Air, water, or land emissions contributing to persistent,
bioaccumulative, and toxic pollution; and
(d) Overall impact to the environment and human health.
(3) Each product stewardship program is encouraged to separate
unwanted products from their original containers, when appropriate,
prior to collection or disposal.
NEW SECTION. Sec. 10 If the department determines that it is
necessary to protect the public from imminent danger, it may
immediately amend, suspend, or cancel approval of a product stewardship
plan without giving the person operating the product stewardship
program an opportunity to be heard. However, the department shall give
the person operating the product stewardship program an opportunity to
be heard through proceedings consistent with the administrative
procedure act, chapter 34.05 RCW, within fifteen days after the date on
which the department takes any of those actions.
NEW SECTION. Sec. 11 (1) The department shall send a written
warning and a copy of this chapter and any rules adopted to implement
this chapter to a producer who is not participating in a product
stewardship program approved by the department and whose covered
product is being sold in or into the state.
(2) A producer not participating in a product stewardship program
approved by the department whose covered product continues to be sold
in or into the state sixty days after receiving a written warning from
the department may be assessed a penalty of ten thousand dollars for
each calendar day that the violation continues. The department may
waive or reduce the penalty if the producer complies with this chapter
and any rules adopted to implement this chapter, to protect public
health, or for any other reason the department determines to be
justified.
(3) If any producer fails to implement its approved plan, the
department may assess a penalty of up to five thousand dollars for the
first violation along with notification that the producer must
implement its plan within thirty days of the violation. After thirty
days, any producer failing to implement their approved plan may be
assessed a penalty of up to ten thousand dollars for the second and
each subsequent violation. A subsequent violation occurs each thirty
days that the producer fails to implement the approved plan.
(4) Any producer, group of producers, or stewardship organization
that does not comply with: (a) The requirement to update its plan
under section 5 of this act; (b) reporting requirements under section
7 of this act; or (c) notification requirements under section 6 of this
act, must first receive a written warning including a copy of the
requirements under this chapter and must be given thirty days to
correct the noncompliance. After thirty days, a person may be assessed
a penalty of up to five thousand dollars for the first violation and up
to ten thousand dollars for the second and each subsequent violation.
A subsequent violation occurs each thirty days that the producer fails
to comply with the requirements under (a) through (c) of this
subsection. The department may waive or reduce the penalty if the
producer, group of producers, or stewardship organization complies with
this chapter and any rules adopted to implement this chapter, to
protect public health, or for any other reason the department
determines to be justified.
(5) All penalties levied under this section must be deposited into
the pharmaceutical product stewardship program account established
under section 15 of this act.
NEW SECTION. Sec. 12 (1) The department shall provide on its web
site a list of all producers participating in product stewardship
programs it has approved and a list of all producers it has identified
as noncompliant with this chapter and any rules adopted to implement
this chapter.
(2) Drug wholesalers must check the department's web site to
determine if producers of products they are wholesaling in or into the
state are in compliance with this chapter. If the drug wholesaler is
unsure of the status of the producer or believes the producer is not in
compliance with this chapter, the drug wholesaler shall contact the
department to determine the producer's status.
(3) The department shall send a written warning and a copy of this
chapter and any rules adopted to implement this chapter to a drug
wholesaler known to be selling a product in or into the state from
producers who are not participating in a product stewardship program or
who are not in compliance with the chapter and rules adopted under this
chapter.
(4) A drug wholesaler who continues to sell a covered product from
a producer that is not participating in an approved product stewardship
program sixty days after receiving a written warning from the
department may be assessed a penalty of ten thousand dollars.
(5) All penalties levied under this section must be deposited into
the pharmaceutical product stewardship program account established
under section 15 of this act.
NEW SECTION. Sec. 13 (1) The department may adopt rules
necessary to implement, administer, and enforce this chapter. The
department must consult with the board on rule development involving
the secure collection, tracking, and handling of drugs collected under
a product stewardship program.
(2) The department may establish performance standards for product
stewardship programs and may establish administrative penalties for
failure to meet the standards.
(3) By December 31, 2014, the department shall report to the
appropriate committees of the legislature concerning the status of the
product stewardship program and recommendations for changes to the
provisions of this chapter.
(4) The department shall annually invite comments from health care
facilities, health care practitioners, pharmacists, local governments,
and citizens on their satisfaction with the services provided by a
product stewardship program. This information must be used by the
department in reviewing proposed plan updates and revisions.
(5) The department shall consult with the board on proposed
provisions of a product stewardship plan involving the secure
collection, tracking, and handling of drugs collected under a product
stewardship program required in section 4(4) of this act.
NEW SECTION. Sec. 14 The department may establish fees for
administering this chapter. The fees may be charged to producers or to
persons operating a product stewardship program. All fees charged must
be based on factors relating to administering this chapter. Fees may
be established in amounts to fully recover and not to exceed expenses
incurred by the department in administering this chapter. The
department may use these fee revenues to reimburse the department for
its costs.
NEW SECTION. Sec. 15 The pharmaceutical product stewardship
program account is created in the custody of the state treasurer. All
receipts from fees and penalties collected under this chapter must be
deposited into the account. Expenditures from the account may be used
only for administering this chapter. Only the director of the
department or the director's designee may authorize expenditures from
the account. The account is subject to allotment procedures under
chapter 43.88 RCW, but an appropriation is not required for
expenditures.
NEW SECTION. Sec. 16 If necessary to ensure that money is
available in the pharmaceutical product stewardship program account
created in section 15 of this act for the initial administration of the
product stewardship program for unwanted drugs from residential
sources, the director of the department may, from time to time, lend
moneys from the state toxics control account created in RCW 70.105D.070
to the pharmaceutical product stewardship program account. These
loaned moneys may be expended solely for the initial administration of
the program by the department under this chapter. The department shall
repay the state toxics control account the amount of moneys loaned plus
interest as determined by the state treasurer within two years of the
date of the loan.
Sec. 17 RCW 69.41.030 and 2003 c 142 s 3 and 2003 c 53 s 323 are
each reenacted and amended to read as follows:
(1) It shall be unlawful for any person to sell, deliver, or
possess any legend drug except upon the order or prescription of a
physician under chapter 18.71 RCW, an osteopathic physician and surgeon
under chapter 18.57 RCW, an optometrist licensed under chapter 18.53
RCW who is certified by the optometry board under RCW 18.53.010, a
dentist under chapter 18.32 RCW, a podiatric physician and surgeon
under chapter 18.22 RCW, a veterinarian under chapter 18.92 RCW, a
commissioned medical or dental officer in the United States armed
forces or public health service in the discharge of his or her official
duties, a duly licensed physician or dentist employed by the veterans
administration in the discharge of his or her official duties, a
registered nurse or advanced registered nurse practitioner under
chapter 18.79 RCW when authorized by the nursing care quality assurance
commission, an osteopathic physician assistant under chapter 18.57A RCW
when authorized by the board of osteopathic medicine and surgery, a
physician assistant under chapter 18.71A RCW when authorized by the
medical quality assurance commission, a physician licensed to practice
medicine and surgery or a physician licensed to practice osteopathic
medicine and surgery, a dentist licensed to practice dentistry, a
podiatric physician and surgeon licensed to practice podiatric medicine
and surgery, or a veterinarian licensed to practice veterinary
medicine, in any province of Canada which shares a common border with
the state of Washington or in any state of the United States:
PROVIDED, HOWEVER, That the above provisions shall not apply to sale,
delivery, or possession by drug wholesalers or drug manufacturers, or
their agents or employees, or to any practitioner acting within the
scope of his or her license, or to a common or contract carrier or
warehouseman, or any employee thereof, whose possession of any legend
drug is in the usual course of business or employment: PROVIDED
FURTHER, That nothing in this chapter or chapter 18.64 RCW shall
prevent a family planning clinic that is under contract with the
department of social and health services from selling, delivering,
possessing, and dispensing commercially prepackaged oral contraceptives
prescribed by authorized, licensed health care practitioners: PROVIDED
FURTHER, That nothing in this chapter shall prevent a licensed
producer, group of producers, or stewardship organization from
operating a pharmaceutical product stewardship program created under
chapter 70.-- RCW (the new chapter created in section 19 of this act)
for the collection, transportation, and disposal of unwanted legend and
nonlegend drugs from consumers or residential sources and not business
entities, for the purpose of disposing of the collected drugs in
compliance with the laws and rules of this state and the United States.
(2)(a) A violation of this section involving the sale, delivery, or
possession with intent to sell or deliver is a class B felony
punishable according to chapter 9A.20 RCW.
(b) A violation of this section involving possession is a
misdemeanor.
NEW SECTION. Sec. 18 Nothing in this chapter changes or limits
the authority of the Washington utilities and transportation commission
to regulate collection of solid waste, including curbside collection of
residential recyclable materials, nor does this chapter change or limit
the authority of a city or town to provide such service itself or by
contract under RCW 81.77.020.
NEW SECTION. Sec. 19 Sections 1 through 16 and 18 of this act
constitute a new chapter in Title
NEW SECTION. Sec. 20 If any provision of this act or its
application to any person or circumstance is held invalid, the
remainder of the act or the application of the provision to other
persons or circumstances is not affected.
NEW SECTION. Sec. 21 This act must be liberally construed to
carry out its purposes and objectives.